Dr. Carla Osiowy


Chief, Viral Hepatitis and Bloodborne Pathogens

Research Scientist

Public Health Agency of Canada

Key publications

Bouckaert, R., Simons, B.C., Krarup, H., Friesen, T.M., and Osiowy, C. (2017) Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling. PeerJ 5:e3757.

Huynh, C., Minuk, G.Y., Uhanova, J., Baikie, M., Wong, T., Osiowy, C. (2017) Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada. Vaccine 35:4515-4522.

Gao, S., Duan, Z., Chen, Y., van der Meer, F., Lee, S.S., Osiowy, C., van Marle, G., Coffin, C.S. (2017) Compartmental HBV evolution and replication in liver and extrahepatic sites after nucleos/tide analogue therapy in chronic hepatitis B carriers. Journal of Clinical Virology 94:8-14.

Osiowy, C., Andonov, A., Fonseca, K., Swidinsky, K., Giles, E., Mason, A., Coffin, C.S. (2017) Transmission of hepatitis D virus between spouses: a longitudinal study of the first reported Canadian case. IDCases 8:37-41.

Osiowy, C., Kowalec, K., and Giles, E. (2016) Discordant diagnostic results due to a hepatitis B virus T123A HBsAg mutant. Diagnostic Microbiology and Infectious Disease 85(3):328-333.

Osiowy, C., Coffin, C., and Andonov, A. (2016) Review of laboratory tests used in monitoring hepatitis B response to pegylated interferon and nucleos(t)ide analog therapy. Current Treatment Options in Infectious Disease 8:177-193.